Literature DB >> 20580881

Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia.

David Kerns1, Ghe S Vong, Kevin Barley, Stella Dracheva, Pavel Katsel, Patrizia Casaccia, Vahram Haroutunian, William Byne.   

Abstract

Deficits in the expression of oligodendrocyte (Ol) and myelin genes have been described in numerous brain regions in schizophrenia (SZ) in association with abnormalities of cell cycle markers. We have previously reported a SZ-associated decrease in the expression of genes expressed after, but not prior to, the terminal differentiation of Ols in the posterior limb of the internal capsule (ICp). This pattern of deficits could reflect a failure of Ol precursors to exit the cell cycle and differentiate to meet the demands imposed by the high rate of apoptosis among myelinating Ols. Here we explore this hypothesis using quantitative real time PCR to examine the mRNA expression of additional genes in the ICp of the previously examined sample of 14 subjects with SZ and 15 normal controls (NCs). The genes examined in the present study were chosen because they are associated with particular phases of the cell cycle (CCND1, CCND2, p21(Cip1), p27(Kip1), and p57(Kip2)), with DNA replication and repair (PCNA), apoptosis (CASP3), or the Notch signaling pathway (JAG1, HES1, HES5, andDTX1). The Notch pathway influences whether Ol precursors continue to proliferate or exit the cell cycle. We also determined the densities of Ols in the ICp. Genes associated with maintenance of the cell cycle tended to exhibit increased expression levels in SZ relative to NCs and to be negatively correlated with the expression levels of the previously assessed mature Ol genes. In contrast, genes associated with cell cycle arrest tended to show the opposite pattern (decreased expression in SZ and positive correlations with mature Ol genes). CASP3 and PCNA expression levels were significantly decreased in SZ and positively correlated with mature Ol genes, suggesting that myelinating Ols may turnover more rapidly in normal controls than in subjects with SZ. JAG1 expression was significantly increased in SZ and exhibited positive correlations with mediators of the canonical Notch pathway but negative correlations with mature Ol genes. Ol densities were significantly decreased in SZ. These data are consistent with the hypothesis that Ol and myelin deficits in SZ involve a failure of Ol precursors to appropriately exit the cell cycle in order to differentiate and mature into myelinating Ols. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580881     DOI: 10.1016/j.schres.2010.04.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  34 in total

Review 1.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

2.  Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.

Authors:  Andrew C Eschenroeder; Allison A Vestal-Laborde; Emilse S Sanchez; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2011-10-14       Impact factor: 7.452

3.  Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia.

Authors:  Hui-Min Fan; Xin-Yang Sun; Wei Niu; Lin Zhao; Qiao-Li Zhang; Wan-Shuai Li; Ai-Fang Zhong; Li-Yi Zhang; Jim Lu
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

4.  Glutamate Transporters: Expression and Function in Oligodendrocytes.

Authors:  Edna Suárez-Pozos; Elizabeth J Thomason; Babette Fuss
Journal:  Neurochem Res       Date:  2019-01-09       Impact factor: 3.996

5.  Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes.

Authors:  Pavel Katsel; Weilun Tan; Bagrat Abazyan; Kenneth L Davis; Christopher Ross; Mikhail V Pletnikov; Vahram Haroutunian
Journal:  Schizophr Res       Date:  2011-05-24       Impact factor: 4.939

Review 6.  Glial cells in schizophrenia: a unified hypothesis.

Authors:  Andrea G Dietz; Steven A Goldman; Maiken Nedergaard
Journal:  Lancet Psychiatry       Date:  2019-11-06       Impact factor: 27.083

7.  Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.

Authors:  Vamshi K Nimmagadda; Christopher T Bever; Narasimha R Vattikunta; Saifi Talat; Vakas Ahmad; Naveen K Nagalla; David Trisler; Susan I V Judge; Walter Royal; Krish Chandrasekaran; James W Russell; Tapas K Makar
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

8.  The neurobiology of transition to psychosis: clearing the cache.

Authors:  Lena Palaniyappan; Tushar Das; Kara Dempster
Journal:  J Psychiatry Neurosci       Date:  2017-09       Impact factor: 6.186

9.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

10.  White matter abnormalities in schizophrenia and schizotypal personality disorder.

Authors:  Marc S Lener; Edmund Wong; Cheuk Y Tang; William Byne; Kim E Goldstein; Nicholas J Blair; M Mehmet Haznedar; Antonia S New; Eran Chemerinski; King-Wai Chu; Liza S Rimsky; Larry J Siever; Harold W Koenigsberg; Erin A Hazlett
Journal:  Schizophr Bull       Date:  2014-06-23       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.